Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Mediated Diseases and Oncology Prepared Remarks Transcript
· seekingalpha.com
Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Mediated Diseases and Oncology June 22, 2026 8:30 AM...
Presentation
Greetings, and welcome to the Nuvectis Pharma Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It's now ...